secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stoke Therapeutics, Inc. (STOK)
CIK:        0001623526
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0001193125-24-156049
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stoke Therapeutics shareholders elect three Class II directors, ratify KPMG as auditor
--------------------------------------------------------------------------------

- Elected Jennifer C. Burstein, Arthur A. Levin, Ph.D., and Ian F. Smith as Class II directors for three-year terms.
- Burstein received 32,396,633 votes for; Levin 25,556,568 for; Smith 33,961,032 for; broker non-votes 5,561,508 each.
- Ratified KPMG as independent auditor for fiscal 2024 with 39,911,634 votes for, 6,826 against, 9,898 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1623526/000119312524156049/0001193125-24-156049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1623526/000119312524156049/d795894d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-156049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer